CAD 92.6
(-1.71%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Revenue | 48.3 Billion | 57.23 Billion | 35.58 Billion | 20.54 Billion | 32.19 Billion | 33.29 Billion |
Cost of Revenue | 41.18 Billion | 47.04 Billion | 31.46 Billion | 22.12 Billion | 29.06 Billion | 29.21 Billion |
Gross Profit | 7.11 Billion | 10.19 Billion | 4.11 Billion | -1.57 Billion | 3.13 Billion | 4.08 Billion |
Operating Expenses | 1.02 Billion | 904 Million | 858 Million | 875 Million | 947 Million | 927 Million |
Selling, General and Administrative Expenses | 939 Million | 899 Million | 826 Million | 862 Million | 900 Million | 908 Million |
Research and Development Expenses | 84 Million | 74 Million | 89 Million | 105 Million | 133 Million | - |
Other Expenses | - | -17 Million | -42 Million | -121 Million | -143 Million | -107 Million |
Cost and Expenses | 42.7 Billion | 47.94 Billion | 32.32 Billion | 22.99 Billion | 30.01 Billion | 30.14 Billion |
Operating Income | 4.61 Billion | 9.28 Billion | 3.25 Billion | -2.44 Billion | 2.18 Billion | 3.15 Billion |
Interest Expense | 69 Million | 60 Million | 54 Million | 64 Million | 93 Million | 108 Million |
Income Tax Expense | 1.48 Billion | 2.14 Billion | 804 Million | -551 Million | -154 Million | 759 Million |
Earnings before Tax | 6.36 Billion | 9.48 Billion | 3.28 Billion | -2.4 Billion | 2.04 Billion | 3.07 Billion |
Net Income | 4.88 Billion | 7.34 Billion | 2.47 Billion | -1.85 Billion | 2.2 Billion | 2.31 Billion |
Earnings Per Share Basic | 8.51 | 11.47 | 3.48 | -2.53 | 2.88 | 2.87 |
Earnings Per Share Diluted | 8.49 | 11.44 | 3.48 | -2.53 | 2.88 | 2.86 |
Weighted Average Shares Outstanding | 574.8 Million | 639.93 Million | 712.35 Million | 735.3 Million | 762.7 Million | 807.5 Million |
Weighted Average Shares Outstanding (Diluted) | 575.9 Million | 641.5 Million | 713.2 Million | 735.3 Million | 765 Million | 810.1 Million |
Gross Margin | 0.15 | 0.18 | 0.12 | -0.08 | 0.10 | 0.12 |
EBIT Margin | 0.17 | 0.20 | 0.15 | 0.04 | 0.12 | 0.14 |
Profit Margin | 0.10 | 0.13 | 0.07 | -0.09 | 0.07 | 0.07 |
EBITDA | 8.07 Billion | 11.18 Billion | 5.23 Billion | 929 Million | 3.63 Billion | 4.6 Billion |
Earnings Before Tax Margin | 0.10 | 0.16 | 0.09 | -0.12 | 0.07 | 0.09 |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
---|---|---|---|---|---|---|
Revenue | 13.25 Billion | 12.69 Billion | 11.65 Billion | 12.38 Billion | 48.3 Billion | 13.21 Billion |
Cost of Revenue | 10.25 Billion | 11 Billion | 9.86 Billion | 10.47 Billion | 41.18 Billion | 10.88 Billion |
Gross Profit | 3 Billion | 1.69 Billion | 1.79 Billion | 1.9 Billion | 7.11 Billion | 2.33 Billion |
Operating Expenses | 1.4 Billion | 221 Million | 248 Million | 252 Million | 944 Million | 258 Million |
Selling, General and Administrative Expenses | 223 Million | 221 Million | 247 Million | 250 Million | - | 257 Million |
Research and Development Expenses | - | - | - | 84 Million | - | - |
Other Expenses | -1.18 Billion | -1.12 Billion | - | - | - | -11.82 Billion |
Cost and Expenses | 11.65 Billion | 11.22 Billion | 10.1 Billion | 10.73 Billion | 42.12 Billion | 11.14 Billion |
Operating Income | 1.6 Billion | 1.46 Billion | 1.55 Billion | 1.65 Billion | 6.17 Billion | 2.07 Billion |
Interest Expense | - | 14 Million | 12 Million | 18 Million | 69 Million | 19 Million |
Income Tax Expense | 366 Million | 356 Million | 377 Million | 375 Million | 1.48 Billion | 499 Million |
Earnings before Tax | 1.6 Billion | 1.48 Billion | 1.57 Billion | 1.74 Billion | 6.36 Billion | 2.1 Billion |
Net Income | 1.23 Billion | 1.13 Billion | 1.19 Billion | 1.36 Billion | 4.88 Billion | 1.6 Billion |
Earnings Per Share Basic | 2.33 | 2.11 | 2.23 | 2.47 | - | 2.77 |
Earnings Per Share Diluted | 2.33 | 2.11 | 2.23 | 2.47 | - | 2.76 |
Weighted Average Shares Outstanding | 530.9 Million | 535.79 Million | 535.8 Million | 552.63 Million | 574.8 Million | 578 Million |
Weighted Average Shares Outstanding (Diluted) | 530.9 Million | 537 Million | 536.9 Million | 553.7 Million | 575.9 Million | 579.3 Million |
Gross Margin | 0.23 | 0.13 | 0.15 | 0.15 | 0.15 | 0.18 |
EBIT Margin | 0.16 | 0.15 | 0.17 | 0.17 | - | 0.19 |
Profit Margin | 0.09 | 0.09 | 0.10 | 0.11 | 0.10 | 0.12 |
EBITDA | 2.11 Billion | 1.92 Billion | 2.04 Billion | 2.14 Billion | - | 2.54 Billion |
Earnings Before Tax Margin | 0.12 | 0.12 | 0.13 | 0.13 | 0.13 | 0.16 |
AMBUJACEM
ESO
TLGY
PPL
NCLTF
3300